Wells Fargo analyst Chris Carey raised the firm’s price target on Procter & Gamble to $165 from $158 and keeps an Overweight rating on the shares. The firm says that the company’s international business looked solid, and if U.S. data improves, Procter & Gambler works. However, “if improves” is the debate.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble upgraded to Overweight from Neutral at JPMorgan
- Procter & Gamble upgraded to Buy from Hold at DBS Bank
- Procter & Gamble Earnings Call: Growth Abroad, Strains at Home
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Procter & Gamble Posts Flat Q2 Results, Maintains 2026 Outlook